CoChat

Common Genetic Variants for Breast Cancer: 32 Largely Refuted Candidates and Larger Prospects

Ioannidis, John P. A. · 2006 · JNCI: Journal of the National Cancer Institute
Cited by 36

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Many common diseases, including most cancers ( 1 ) , may have a component of inheritance that is due to low-penetrance, common genetic variants. However, identifying these variants has been a challenge. In this issue of the Journal, the Breast Cancer Association Consortium reports an impressive collaborative effort—the large-scale evaluation of 16 single nucleotide polymorphisms (SNPs) that have been previously hypothesized to modify susceptibility to breast cancer ( 2 ) . Despite accumulated genotype information on 12 000–32 000 breast cancer case and control subjects for each SNP, results are largely null. No SNP shows an association with P <.0031, the threshold required after adjusting for 16 tests. Five variants with P values between .009 and .06 require further testing, but the odds ratios (ORs) are already hovering at around 0.9–1.1. For the other 11 SNPs, results are even more conclusively null. Extensive subgroup analyses largely reinforce these conclusions. These data add to the tribulations of the “candidate gene” approach that has guided complex disease genetics for over a decade. In this approach, biologic pathways thought to be relevant to specific diseases were scrutinized for gene variants modulating disease risk. Postulated associations were then often extended to other phenotypes, with or without much rationale for the extension ( 3 ) . The gene–disease association literature grew exponentially. In 2005 alone, 194 original research articles were published that probed gene–disease associations for breast cancer ( 4 ) ; I selected every 10th article (n = 19) for perusal. Fifteen of these articles claimed associations overall, in subgroups, or for specific outcomes. The parade of claimed associated genes in this tiny sample is already impressive: HER2 , IL10 , NCOA3 , TGFBR1 , TGFB1 , ESR2 , HFE , IGF-I , ESR1 , AR , CHEK2 , PAI-1 , XRCC1 , HSMH2 , SULT1A1 , and IFNG. If all these claimed associations are real, a 10% sample of the published genetic association research in a single year alone seemingly suffices to explain all that causes breast cancer: the total attributable fraction from this small sample of associations already reaches close to 100%. Is this an apotheosis of data dredging? Even in my small sample of 19 articles, one comes across an association that is statistically significant only in the sub-sub-subgroup of postmenopausal women who have at least three pregnancies and also have no wild-type allele ( 5 ) ; a polymorphism with statistically significantly decreased risk for early-stage breast cancer but increased risk for advanced-stage disease ( 6 ) ; another increasing the risk especially for grade 3 tumors ( 7 ) ; a marker with 13 variants, of which one shows a statistically significant association versus all others combined, while hundreds of different groupings are conceivable ( 8 ) ; polymorphisms that have no statistically significant associations on their own but do in one of their many constructed haplotypes ( 9 ) ; joint effects of polymorphisms of different genes acting in obvious ( 10 ) or not-so-obvious ( 11 ) pathways; associations that are not even tested statistically ( 12 ) ; and so forth. In addition to the 16 SNPs examined by the Breast Cancer Association Consortium, meta-analyses of published data are available for another 16 candidate gene variants in breast cancer ( Table 1 ) ( 8 , 13 – 19 ) . When compared with the odds ratios in the first studies published on each of these 16 variants, the odds ratios in the meta-analyses typically converge to the null ( Fig. 1 ), as shown also in genetic association studies in other diseases ( 20 – 22 ) . For three SNPs, meta-analyses still reached P <.05 (i.e., the odds ratios were statistically significantly different from 1.0), but all three associations are implausible. For H-ras-1 rare alleles, early studies used erroneous allele calling methods ( 23 , 24 ) ; recent larger studies have found no association ( 19 ) . The borderline association of GSTT1 is justly dismissed by the meta-analysis authors ( 17 ) ; the miniscule effect is driven by very small studies. Finally, in the case of IGF-I , a polymorphic marker was categorized arbitrarily in two categories ( 8 ) . More recent studies claim effects in the opposite direction or with different categorizations ( 25 , 26 ) , and opposing effects might cancel out in an updated meta-analysis. Meta-analyses of breast cancer candidate gene variants and regression to the null. The 16 hypothesized gene–disease associations listed in Table 1 are shown. For each association, a line connects the results of the first published study (odds ratio [OR] as a function of sample size) with the summary results of the meta-analysis. Not shown are H-ras-1 rare alleles, which are outliers (OR = 6.5 in first study of 160 subjects and OR = 2.7 in meta-analysis of 1631 subjects; however, the associations were refuted by subsequent evidence). Genetic contrasts are as per Table 1 ; for associat

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djj392

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 36

Metadata

Authors
Ioannidis, J. P. A.
Venue
JNCI: Journal of the National Cancer Institute
Published
2006-10-04
Volume
98
Issue
19
Pages
1350-1353
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2104322599
Cited by
36
References
3
FWCI
3.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Common Genetic Variants for Breast Cancer: 32 Largely Refuted Candidates and Larger Prospects. https://app.cochat.ai/papers/10.1093/jnci/djj392
The paper
Ioannidis, J. P. A. (2006). Common Genetic Variants for Breast Cancer: 32 Largely Refuted Candidates and Larger Prospects. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djj392

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.